← Browse by Condition
Medical Condition

radiomics

Total Trials
3
Recruiting Now
3
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for radiomics sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Top Sponsors
Second Affiliated Hospital, School of Medicine, Zhejiang University 1 trial
First Affiliated Hospital, Sun Yat-Sen University 1 trial
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 1 trial
NCT04483804
Recruiting

Application of Radiomics in Breast Cancer

Enrollment
2,000 pts
Location
China
Sponsor
Second Affiliated Hospital, Sc...
View Trial →
NCT06452550
Recruiting

Neurophenotype Predicts CD Disease Progression

Enrollment
500 pts
Location
China
Sponsor
First Affiliated Hospital, Sun...
View Trial →
NCT07030569
Recruiting

RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study

Enrollment
500 pts
Location
Italy
Sponsor
Fondazione IRCCS Istituto Nazi...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology